Atyr Pharma Inc

-0.08 (-3.26%)
5:40:34 PM EDT: $2.40 +0.03 (+1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)68.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.42 Million
Adjusted EPS-$0.48
See more estimates
10-Day MA$2.38
50-Day MA$2.24
200-Day MA$2.96
See more pivots

Atyr Pharma Inc Stock, NASDAQ:LIFE

3545 John Hopkins Court, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.731.8389
Number of Employees: 53


aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.